Worldwide Pulmonary Arterial Hypertension Industry to 2025 - Featuring Gilead Sciences, United Therapeutics and Novartis International Among Others
January 20, 2021 06:33 ET
|
Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Pulmonary Arterial Hypertension (2020-2025) by Drug Class, Route of Administration, Distribution Mode, Geography, Competitive Analysis and the...
Pulmonary Arterial Hypertension Market to reach a valuation of US$5.19 Bn by 2020, Says TMR
July 24, 2018 07:27 ET
|
Transparency Market Research
Albany, NY, July 24, 2018 (GLOBE NEWSWIRE) -- According to TMR, the global pulmonary arterial hypertension therapeutics market is expected to reach a valuation of US$ 5.19 bn by the end of 2020. The...